Climacteric

Papers
(The median citation count of Climacteric is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-08-01 to 2024-08-01.)
ArticleCitations
Premature ovarian insufficiency: an International Menopause Society White Paper133
Osteoporosis and fractures in women: the burden of disease89
Hormone replacement therapy – where are we now?64
Insomnia and menopause: a narrative review on mechanisms and treatments51
Three-dimensional bioprinting of artificial ovaries by an extrusion-based method using gelatin-methacryloyl bioink42
Vaginal lubricants and moisturizers: a review into use, efficacy, and safety41
CO2 laser and the genitourinary syndrome of menopause: a randomized sham-controlled trial38
Histological findings after non-ablative Er:YAG laser therapy in women with severe vaginal atrophy32
The effects of phytoestrogens on postmenopausal health32
Brain fog in menopause: a health-care professional’s guide for decision-making and counseling on cognition30
The global prevalence of premature ovarian insufficiency: a systematic review and meta-analysis29
Review & meta-analysis: isopropanolic black cohosh extract iCR for menopausal symptoms – an update on the evidence26
Cardiometabolic health in premature ovarian insufficiency25
Fracture risk assessment by the FRAX model25
Bone health 2022: an update24
Safety of vaginal erbium laser: A review of 113,000 patients treated in the past 8 years24
Hormone replacement therapy and cervical cancer: a systematic review of the literature23
Premature or early bilateral oophorectomy: a 2021 update23
Endometriosis-associated cancer22
Skin, hair and beyond: the impact of menopause21
Dietary intake and menopausal symptoms in postmenopausal women: a systematic review20
Menopause and cognitive complaints: are ovarian hormones linked with subjective cognitive decline?19
Selective estrogen receptor modulators and bone health19
The treatment of menopausal symptoms by traditional Chinese medicine in Asian countries19
Medical treatment of osteoporosis17
Hyaluronic acid in vulvar and vaginal administration: evidence from a literature systematic review15
Cognitive profiles in perimenopause: hormonal and menopausal symptom correlates14
Estrogen receptor α: a critical role in successful female cognitive aging14
Health-care providers’ views of menopause and its management: a qualitative study14
Knowledge and awareness toward menopause and hormone therapy among premenopausal women in Jordan13
Dry eye disease symptoms and quality of life in perimenopausal and postmenopausal women13
Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study12
Premenopausal osteoporosis12
Effects of exercise on vasomotor symptoms in menopausal women: a systematic review and meta-analysis12
A pas de deux of osteoporosis and sarcopenia: osteosarcopenia11
A research primer for studies of cognitive changes across the menopause transition11
Lasers in the era of evidence-based medicine11
Effects of non-ablative vaginal erbium:YAG laser treatment for interstitial cystitis/bladder pain syndrome: a case series (UNICORN-2 study)11
First live birth in China after cryopreserved ovarian tissue transplantation to prevent premature ovarian insufficiency11
Physiologic and psychosocial changes of the menopause transition in US Latinas: a narrative review10
New insights into the diagnosis and management of bone health in premature ovarian insufficiency10
Menopause, hormone therapy and cognition: maximizing translation from preclinical research10
Vaginal collagen I and III changes after carbon dioxide laser application in postmenopausal women with the genitourinary syndrome: a pilot study10
Neurokinin 3 receptor antagonists – prime time?10
Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy10
Uterine bleeding with hormone therapies in menopausal women: a systematic review9
Does the environment affect menopause? A review of the effects of endocrine disrupting chemicals on menopause9
Clinical practice of traditional Chinese medicine for the treatment of postmenopausal osteoporosis: a literature review9
Postmenopausal hyperandrogenism9
Hysteroscopic laser ablation of symptomatic uterine fibroids: insights from a prospective study9
Novel approaches to fertility restoration in women with premature ovarian insufficiency9
Menopausal hormone therapy: why we should no longer be afraid of the breast cancer risk9
Effects of resistance training on quality of life in postmenopausal women with vasomotor symptoms9
The effects of hormone replacement therapy on the microbiomes of postmenopausal women9
First pregnancy in China after ovarian tissue transplantation to prevent premature ovarian insufficiency9
Precision hormone therapy: identification of positive responders9
Impact of estetrol (E4) on hemostasis, metabolism and bone turnover in postmenopausal women8
Lessons from KEEPS: the Kronos Early Estrogen Prevention Study8
Vaginal laser therapy for GSM/VVA: where we stand now – a review by the EUGA Working Group on Laser8
Sustainability of vaginal estrogens for genitourinary syndrome of menopause – a systematic review8
Relationship between the type of hormone replacement therapy and incidence of breast cancer in Korea8
PGRMC1 promotes triple-negative breast cancer cell growth via suppressing ferroptosis8
Safety of prasterone in breast cancer survivors treated with aromatase inhibitors: the VIBRA pilot study8
The impact of cannabis use on vasomotor symptoms, mood, insomnia and sexuality in perimenopausal and postmenopausal women: a systematic review8
The severe acute respiratory syndrome due to coronavirus 2 (SARS-CoV-2) infection and the climacteric woman8
Update on bone health: the International Menopause Society White Paper 20218
Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study8
Hormone therapy for postmenopausal osteoporosis management7
The impact of micronized progesterone on cardiovascular events – a systematic review7
The 2023 Practitioner’s Toolkit for Managing Menopause7
The role of estrogens in osteosarcopenia: from biology to potential dual therapeutic effects7
Association of bilateral oophorectomy and menopause hormone therapy with mild cognitive impairment: the REDLINC X study7
Reproductive milestones across the lifespan and cardiovascular disease risk in women7
Polycystic ovary syndrome: associations with cardiovascular disease7
Internet Of Things and women’s health7
Peer review: the cornerstone of scientific publishing integrity7
Fracture recurrence in hip fracture with menopausal hormone therapy versus risedronate: a clinical trial7
Bioidentical hormones7
Er:YAG laser in hysterectomized women with stress urinary incontinence: a VELA retrospective cohort, non-inferiority study6
Osteoanabolic therapy for osteoporosis in women6
Treatment indications and thresholds of intervention: consensus and controversies in osteoporosis6
E2 + norethisterone promotes the PI3K–AKT pathway via PGRMC1 to induce breast cancer cell proliferation6
Compounded bioidentical menopausal hormone therapy – a physician perspective6
Associations between WNT signaling pathway-related gene polymorphisms and risks of osteoporosis development in Chinese postmenopausal women: a case–control study6
Treating genitourinary syndrome of menopause in breast cancer survivors: main challenges and promising strategies6
Association of menopausal status and symptoms with depressive symptoms in middle-aged Chinese women6
Premature ovarian insufficiency: a toolkit for the primary care physician6
Quality of life in menopausal women in the workplace – a systematic review6
Relationship between vasomotor symptoms and metabolic syndrome in Chinese middle-aged women6
Impact of progesterone on the gastrointestinal tract: a comprehensive literature review6
Weight gain in menopause: systematic review of adverse events in women treated with black cohosh6
Changes in high-sensitivity C-reactive protein levels and metabolic indices according to grip strength in Korean postmenopausal women6
Evaluation of the relationship between homocysteine levels and bone mineral density in postmenopausal women6
Vulvodynia – an evolving disease5
The first major complication due to laser treatment for stress urinary incontinence: a short report5
Interactions between estradiol, diabetes, and brain aging and the risk for cognitive impairment5
Celiac disease and bone health: is there a gap in the management of postmenopausal osteoporosis?5
Prediction of premature ovarian insufficiency: foolish fallacy or feasible foresight?5
Pelvic floor muscle rehabilitation for genitourinary syndrome of menopause: why, how and when?5
Glycyrrhizin improves bone metabolism in ovariectomized mice via inactivating NF-κB signaling5
Menopausal hormone therapy and coronary heart disease: the roller-coaster history5
Resveratrol promotes bone mass in ovariectomized rats and the SIRT1 rs7896005 SNP is associated with bone mass in women during perimenopause and early postmenopause5
Pulmonary embolism in menopausal hormone therapy: a population-based register study5
Women and COVID-19: severity and mortality in hospitalized middle-aged and older patients5
Primary choice of estrogen and progestogen as components for HRT: a clinical pharmacological view5
Evidence synthesis in the time of COVID-195
Impact of progesterone on skin and hair in menopause – a comprehensive review5
Sequential treatment in vulvovaginal atrophy5
Fat mass, weight and body shape changes at menopause – causes and consequences: a narrative review5
Satisfaction and medication adherence in women with vulvovaginal atrophy: the CRETA5
Transgender health and the impact of aging and menopause5
Genitourinary syndrome of menopause in Chinese perimenopausal and postmenopausal women5
Understanding of and clinical approach to cardiometabolic transition at the menopause5
Menopausal hormonal therapy in surgically menopausal women with underlying endometriosis4
SUI in postmenopausal women: advantages of an intraurethral + intravaginal Er:YAG laser4
Relation between blood pressure and genito-urinary symptoms in the years across the menopausal age4
The impact of menopause education on quality of life among menopausal women: a systematic review with meta-analysis4
Effects of royal jelly on bone metabolism in postmenopausal women: a randomized, controlled study4
Progress in understanding and management of premature ovarian insufficiency4
Premature ovarian insufficiency and autoimmune profiles: a prospective case–control study4
Postmenopausal women’s cognitive function and performance of virtual reality tasks4
Alterations of regional homogeneity in perimenopause: a resting-state functional MRI study4
Different local estrogen therapies for a tailored approach to GSM4
Evaluation and management of endometriosis4
A bibliometric analysis of primary ovarian insufficiency from 2010 to 20204
It starts from the womb: maximizing bone health4
Estradiol selectively regulates metabolic substrates across memory systems in models of menopause4
Fezolinetant for the treatment of vasomotor symptoms associated with menopause: a meta-analysis4
Premature ovarian insufficiency – the need for a genomic map4
Effects of ospemifene on overactive bladder in postmenopausal women with vulvovaginal atrophy4
Use of MHT in women with cardiovascular disease: a systematic review and meta-analysis4
Evaluating the menopausal transition with the STRAW + 10 in a Brazilian cohort of women with HIV, 2015–20164
Effect of surgical menopause and frontal lobe cognitive function4
Menopause and diabetes4
Xiangshao granules can relieve emotional symptoms in menopausal women: a randomized controlled trial4
Testosterone for women: certainties and uncertainties4
Overexpression of miR-181a regulates the Warburg effect in triple-negative breast cancer4
International Society for the Study of Women's Sexual Health Clinical Practice Guideline for the Use of Systemic Testosterone for Hypoactive Sexual Desire Disorder in Women4
Are we assessing genitourinary syndrome of menopause properly?4
Androgens in premenopausal women and women with premature ovarian insufficiency3
The promotion of menopausal hormone therapy might be determined by the attitude of health-care professionals3
Vasomotor symptoms and cardiovascular health: findings from the SWAN and the MsHeart/MsBrain studies3
Swiss consensus on the role of DHEA in the management of genitourinary syndrome of menopause3
A disease of her own? Unique features of heart failure in women3
Vulvovaginal atrophy management with a laser: the placebo effect or the conditioning Pavlov reflex3
Efficacy of low-dose vaginal 17β-estradiol versus vaginal promestriene for vulvovaginal atrophy3
Genistein for glycolipid metabolism in postmenopausal women: a meta-analysis3
The yin and yang of GSM and low sexual desire3
Scientific insights into brain fog during the menopausal transition3
The heat is on3
What is in a name? A decade after changing from VVA to GSM have we come any closer to ending the ‘silent suffering’ of postmenopausal women with genitourinary symptoms?3
Bone-friendly lifestyle and the role of calcium or vitamin D supplementation3
Hormone therapy effect on menopausal systemic lupus erythematosus patients: a systematic review3
Breast cancer therapy and bone3
A review of the impact of hormone therapy on prefrontal structure and function at menopause3
A pilot screening study for low bone mass in Singaporean women using years since menopause and BMI3
The role of medications in successful aging3
Effect of external sleep disturbance on sleep architecture in perimenopausal and postmenopausal women3
Menopause care delivery in the time of COVID-19: evaluating the acceptability of telehealth services for women with early and usual age menopause3
Efficacy of intradermal hyaluronic acid plus polynucleotides in vulvovaginal atrophy: a pilot study3
Expert opinion on the treatment of vulvovaginal atrophy with ospemifene based on new evidence3
Ultra-low-dose estradiol and dydrogesterone: a phase III study for vasomotor symptoms in China3
Prevalence of mild cognitive impairment in surgical menopause: subtypes and associated factors3
Use of a vaginal CO2 laser for the management of genitourinary syndrome of menopause in gynecological cancer survivors: a systematic review2
Associations of fat mass index with hot flashes and lean mass index with insomnia in middle-aged women2
Lichen sclerosus of the vulva2
Menopausal hormone therapy: what are the problems in the perception of Chinese physicians?2
Vaginal Health: Insights, Views & Attitudes survey in Latin America (VIVA-LATAM): focus on Brazil2
The role of microbiota in the management of genitourinary syndrome of menopause2
Pregnancy-associated risk factors for future cardiovascular disease – early prevention strategies warranted2
Pharmacokinetics, safety and preliminary pharmacodynamic evaluation of DARE-VVA1: a soft gelatin capsule containing tamoxifen for the treatment of vulvovaginal atrophy2
God, spirituality and religion in women dying from gynecological cancer2
Use of interventions involving virtual reality tasks during the climacteric: a systematic review2
Impact of overweight and obesity in postmenopausal women2
Longitudinal relationships between self-compassion and depressive symptoms in midlife women2
Validation of a clinical tool for vestibular trophism in postmenopausal women2
Diagnosis and medical management of abnormal premenopausal and postmenopausal bleeding2
Peer review? No thanks!2
Using menopausal hormone therapy to prevent fracture recurrence in older women: is it time to change our opinion?2
Recent advances in the management of postmenopausal women with non-atypical endometrial hyperplasia2
The rs2165241 polymorphism of the Loxl1 gene in postmenopausal women with pelvic organ prolapse2
Association between coronary artery vitamin D receptor expression and select systemic risks factors for coronary artery atherosclerosis2
The mediating role of socioeconomic status on the relationship between pregnancy history and later-life cognition2
Long-term clinical and histological safety and efficacy of the CO 2 laser for treatment of genitourinary syndrome of menopause: an original study2
IGF-1R/β-catenin signaling axis is implicated in streptozotocin exacerbating bone impairment in ovariectomized rats2
Early decrease in lean mass and bone mass in postmenopausal women: a cross-sectional study2
Estrone, sex hormone binding globulin and lipid profiles in older women: an observational study2
Differences in patient-reported hormone therapy use for menopause symptoms by provider specialty2
Menopause, aging and the failing pelvic floor: a clinician’s view2
Determinants of attained estradiol levels in response to oral estradiol plus progesterone therapy2
Clinical impact of misinterpretation of dual-energy X-ray absorptiometry during the evaluation of osteoporotic patients2
The WHO claims estrogens are ‘carcinogenic’: is this true?2
Effect of menopausal symptom treatment options on palpitations: a systematic review2
‘Vaginal Laser Therapy for GSM/VVA: Where We Stand Now – A Review by the EUGA Working Group on Laser’2
Closing the gap: cardiovascular disease in women2
Effect of estrogen on vaginal complications of pessary use: a systematic review and meta-analysis2
Breast cancer genetics and risk assessment: an overview for the clinician2
Depression in midlife women attending a menopause clinic is associated with a history of childhood maltreatment2
Estrogen as a guardian of auditory health: Tsp1–CD47 axis regulation and noise-induced hearing loss2
Menopause symptoms, sexual dysfunctions and pelvic floor disorders in refugee and asylum seeker women: a scoping review2
Impacts of menopause hormone therapy on mood disorders among postmenopausal women2
Women’s cardiovascular health – the cardio-oncologic jigsaw2
Menopause status and climacteric symptoms in a birth cohort of mid-life New Zealand women2
Postmenopausal women’s adherence to pelvic floor muscle exercises over 2 years2
Impact of age and menopausal stage on serum anti-Müllerian hormone levels in middle-aged women2
Effect of hormone replacement therapy on intervertebral disc height2
Urinary incontinence as a marker of temporality in women: a qualitative study2
0.036424875259399